Bsw Wealth Partners Amgen Inc Transaction History

Bsw Wealth Partners

$661 Million
Q3 2024

A detailed history of Bsw Wealth Partners transactions in Amgen Inc stock. As of the latest transaction made, Bsw Wealth Partners holds 2,290 shares of AMGN stock, worth $673,260. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,290

Previous 2,633 13.03%

Holding current value

$673,260

Previous $822,000 10.34%

% of portfolio

0.11%

Previous 0.14%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $106,117 - $115,721	-343 Reduced 13.03%	2,290 $737,000
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $54,914 - $66,735	-209 Reduced 7.35%	2,633 $822,000
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $1,344 - $1,622	5 Added 0.18%	2,842 $808,000
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $6,136 - $6,923	-24 Reduced 0.84%	2,837 $817,000
Q3 2023 Oct 27, 2023	BUY	$218.65 - $271.46 $57,067 - $70,851	261 Added 10.04%	2,861 $768,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $1,714 - $2,026	-8 Reduced 0.31%	2,600 $577,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $42,674 - $52,012	-189 Reduced 6.76%	2,608 $630,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $44,202 - $56,164	193 Added 7.41%	2,797 $734,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $313,346 - $353,397	-1,396 Reduced 34.9%	2,604 $587,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $58,600 - $65,211	-254 Reduced 5.97%	4,000 $973,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $152,831 - $169,071	697 Added 19.6%	4,254 $1.03 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $35,400 - $40,512	-178 Reduced 4.77%	3,557 $800,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $26,746 - $31,336	126 Added 3.49%	3,735 $794,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $66,103 - $73,336	283 Added 8.51%	3,609 $880,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $23,744 - $27,670	107 Added 3.32%	3,326 $827,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $74,218 - $88,380	343 Added 11.93%	3,219 $740,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $121,783 - $135,433	519 Added 22.02%	2,876 $731,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $26,506 - $32,527	-134 Reduced 5.38%	2,357 $556,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $7,836 - $10,393	43 Added 1.76%	2,491 $505,000
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $463,186 - $595,353	2,448 New	2,448 $590,000
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $405,153 - $485,458	-2,327 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $11,835 - $13,874	71 Added 3.15%	2,327 $429,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $1,989 - $2,242	11 Added 0.49%	2,256 $429,000
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $2,194 - $2,451	13 Added 0.58%	2,245 $390,000
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $373,391 - $426,312	2,232	2,232 $416,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.

Account

Bsw Wealth Partners Amgen Inc Transaction History